Biomodulatory approaches to photodynamic therapy for solid tumors
- PMID: 22842096
- PMCID: PMC3459352
- DOI: 10.1016/j.canlet.2012.07.026
Biomodulatory approaches to photodynamic therapy for solid tumors
Abstract
Photodynamic Therapy (PDT) uses a photosensitizing drug in combination with visible light to kill cancer cells. PDT has an advantage over surgery or ionizing radiation because PDT can eliminate tumors without causing fibrosis or scarring. Disadvantages include the dual need for drug and light, and a generally lower efficacy for PDT vs. surgery. This minireview describes basic principles of PDT, photosensitizers available, and aspects of tumor biology that may provide further opportunities for treatment optimization. An emerging biomodulatory approach, using methotrexate or Vitamin D in combination with aminolevulinate-based PDT, is described. Finally, current clinical uses of PDT for solid malignancies are reviewed.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Figures
References
-
- Moan J, Peng Q. An outline of the history of PDT. In: Patrice T, editor. Photodynamic Therapy, The Royal Society of Chemistry. Cambridge, UK: 2003. pp. 3–15. www.rsc.org.
-
- Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38:2628–2635. - PubMed
-
- Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst. 1993;85:443–456. - PubMed
-
- Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–387. - PubMed
-
- Hasan T, Ortel B, Solban N, Pogue BW. Photodynamic therapy of cancer. In: Kufe D, Bast R, Hait W, Hong W, Pollock R, Weichselbaum R, Holland J, Frei E, editors. Cancer Medicine. 7th edition BC Decker, Inc.; Hamilton, Ontario: 2006. pp. 537–548.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
